Avinger (NASDAQ:AVGR – Get Free Report) and Sintx Technologies (NASDAQ:SINT – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, analyst recommendations, dividends, risk, earnings, valuation and institutional ownership.
Insider & Institutional Ownership
18.3% of Avinger shares are held by institutional investors. Comparatively, 18.4% of Sintx Technologies shares are held by institutional investors. 42.8% of Avinger shares are held by company insiders. Comparatively, 0.0% of Sintx Technologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Analyst Ratings
This is a breakdown of recent ratings and target prices for Avinger and Sintx Technologies, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Avinger | 0 | 0 | 1 | 0 | 3.00 |
| Sintx Technologies | 0 | 1 | 0 | 0 | 2.00 |
Profitability
This table compares Avinger and Sintx Technologies’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Avinger | -261.06% | -5,527.11% | -123.25% |
| Sintx Technologies | -358.79% | -140.68% | -78.29% |
Risk and Volatility
Avinger has a beta of 1.15, meaning that its stock price is 15% more volatile than the S&P 500. Comparatively, Sintx Technologies has a beta of 1.49, meaning that its stock price is 49% more volatile than the S&P 500.
Earnings & Valuation
This table compares Avinger and Sintx Technologies”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Avinger | $7.26 million | 0.26 | -$18.32 million | ($11.06) | -0.05 |
| Sintx Technologies | $1.64 million | 2.78 | -$8.26 million | ($50.56) | -0.07 |
Sintx Technologies has lower revenue, but higher earnings than Avinger. Sintx Technologies is trading at a lower price-to-earnings ratio than Avinger, indicating that it is currently the more affordable of the two stocks.
Summary
Avinger beats Sintx Technologies on 8 of the 14 factors compared between the two stocks.
About Avinger
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. Its lumivascular products comprise Lightbox imaging consoles; the Ocelot and Tigereye family of devices, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. The company is also developing IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is based in Redwood City, California.
About Sintx Technologies
Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
Receive News & Ratings for Avinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avinger and related companies with MarketBeat.com's FREE daily email newsletter.
